{"id":"https://openalex.org/W4416638411","doi":"https://doi.org/10.1183/13993003.congress-2025.oa1201","title":"Seralutinib targets fibrotic pathways in IPF: Evidence from single-cell transcriptomics","display_name":"Seralutinib targets fibrotic pathways in IPF: Evidence from single-cell transcriptomics","publication_year":2025,"publication_date":"2025-09-27","ids":{"openalex":"https://openalex.org/W4416638411","doi":"https://doi.org/10.1183/13993003.congress-2025.oa1201"},"language":"en","primary_location":{"id":"doi:10.1183/13993003.congress-2025.oa1201","doi":"https://doi.org/10.1183/13993003.congress-2025.oa1201","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2025.oa1201","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular pathology and functional genomics","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039489405","display_name":"Rui Benfeitas","orcid":"https://orcid.org/0000-0001-7972-0083","observed_orcids":["https://orcid.org/0000-0001-7972-0083"]},"institutions":[{"id":"https://openalex.org/I4210162628","display_name":"Chiesi (Italy)","ror":"https://ror.org/0511bn634","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210162628"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Rui Benfeitas","raw_affiliation_strings":["1Chiesi Farmaceutici S.p.A., Parma, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Chiesi Farmaceutici S.p.A., Parma, Italy","institution_ids":["https://openalex.org/I4210162628"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031852566","display_name":"Robin E. Osterhout","orcid":"https://orcid.org/0000-0003-1146-9915","observed_orcids":["https://orcid.org/0000-0003-1146-9915"]},"institutions":[{"id":"https://openalex.org/I4210111220","display_name":"Gossamer Bio (United States)","ror":"https://ror.org/01qp02p38","country_code":"US","type":"company","lineage":["https://openalex.org/I4210111220"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robin Osterhout","raw_affiliation_strings":["2Gossamer Bio, Inc., San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Gossamer Bio, Inc., San Diego, CA, United States","institution_ids":["https://openalex.org/I4210111220"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Eduardo Garcia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111220","display_name":"Gossamer Bio (United States)","ror":"https://ror.org/01qp02p38","country_code":"US","type":"company","lineage":["https://openalex.org/I4210111220"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eduardo Garcia","raw_affiliation_strings":["2Gossamer Bio, Inc., San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Gossamer Bio, Inc., San Diego, CA, United States","institution_ids":["https://openalex.org/I4210111220"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037554428","display_name":"Ravikumar A. Sitapara","orcid":"https://orcid.org/0000-0003-2366-6254","observed_orcids":["https://orcid.org/0000-0003-2366-6254"]},"institutions":[{"id":"https://openalex.org/I4210111220","display_name":"Gossamer Bio (United States)","ror":"https://ror.org/01qp02p38","country_code":"US","type":"company","lineage":["https://openalex.org/I4210111220"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ravikumar Sitapara","raw_affiliation_strings":["2Gossamer Bio, Inc., San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Gossamer Bio, Inc., San Diego, CA, United States","institution_ids":["https://openalex.org/I4210111220"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036654862","display_name":"Vanessa Pitozzi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162628","display_name":"Chiesi (Italy)","ror":"https://ror.org/0511bn634","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210162628"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Vanessa Pitozzi","raw_affiliation_strings":["1Chiesi Farmaceutici S.p.A., Parma, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Chiesi Farmaceutici S.p.A., Parma, Italy","institution_ids":["https://openalex.org/I4210162628"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085197005","display_name":"Sidra Hoffman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111220","display_name":"Gossamer Bio (United States)","ror":"https://ror.org/01qp02p38","country_code":"US","type":"company","lineage":["https://openalex.org/I4210111220"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sidra Hoffman","raw_affiliation_strings":["2Gossamer Bio, Inc., San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Gossamer Bio, Inc., San Diego, CA, United States","institution_ids":["https://openalex.org/I4210111220"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Lawrence Ho","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111220","display_name":"Gossamer Bio (United States)","ror":"https://ror.org/01qp02p38","country_code":"US","type":"company","lineage":["https://openalex.org/I4210111220"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lawrence Ho","raw_affiliation_strings":["2Gossamer Bio, Inc., San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Gossamer Bio, Inc., San Diego, CA, United States","institution_ids":["https://openalex.org/I4210111220"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025818724","display_name":"Zhaoqing Ding","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111220","display_name":"Gossamer Bio (United States)","ror":"https://ror.org/01qp02p38","country_code":"US","type":"company","lineage":["https://openalex.org/I4210111220"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhaoqing Ding","raw_affiliation_strings":["2Gossamer Bio, Inc., San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Gossamer Bio, Inc., San Diego, CA, United States","institution_ids":["https://openalex.org/I4210111220"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Lu\u00eds Magalh\u00e3es","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162628","display_name":"Chiesi (Italy)","ror":"https://ror.org/0511bn634","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210162628"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Lu\u00eds Magalh\u00e3es","raw_affiliation_strings":["1Chiesi Farmaceutici S.p.A., Parma, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Chiesi Farmaceutici S.p.A., Parma, Italy","institution_ids":["https://openalex.org/I4210162628"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079788735","display_name":"Silvia Parolo","orcid":"https://orcid.org/0000-0002-3671-5353","observed_orcids":["https://orcid.org/0000-0002-3671-5353"]},"institutions":[{"id":"https://openalex.org/I2802934434","display_name":"The Microsoft Research - University of Trento Centre for Computational and Systems Biology","ror":"https://ror.org/04kcgyj43","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I1290206253","https://openalex.org/I193223587","https://openalex.org/I2802934434","https://openalex.org/I4210164937"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Silvia Parolo","raw_affiliation_strings":["3Fondazione the Microsoft Research-University of Trento Centre for Computational and Systems Biology (COSBI), Rovereto, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Fondazione the Microsoft Research-University of Trento Centre for Computational and Systems Biology (COSBI), Rovereto, Italy","institution_ids":["https://openalex.org/I2802934434"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107848786","display_name":"Richard Aranda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111220","display_name":"Gossamer Bio (United States)","ror":"https://ror.org/01qp02p38","country_code":"US","type":"company","lineage":["https://openalex.org/I4210111220"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard Aranda","raw_affiliation_strings":["2Gossamer Bio, Inc., San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Gossamer Bio, Inc., San Diego, CA, United States","institution_ids":["https://openalex.org/I4210111220"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025077014","display_name":"Gisli R. Jenkins","orcid":"https://orcid.org/0000-0002-7929-2119","observed_orcids":["https://orcid.org/0000-0002-7929-2119"]},"institutions":[{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"G\u00edsli Jenkins","raw_affiliation_strings":["4National Heart and Lung Institute, Imperial College London, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4National Heart and Lung Institute, Imperial College London, London, United Kingdom","institution_ids":["https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058325633","display_name":"Toby M. Maher","orcid":"https://orcid.org/0000-0001-7192-9149","observed_orcids":["https://orcid.org/0000-0001-7192-9149"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Toby M. Maher","raw_affiliation_strings":["5Keck School of Medicine of USC, Los Angeles, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Keck School of Medicine of USC, Los Angeles, CA, United States","institution_ids":["https://openalex.org/I1174212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108199232","display_name":"Jean-Marie Bruey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111220","display_name":"Gossamer Bio (United States)","ror":"https://ror.org/01qp02p38","country_code":"US","type":"company","lineage":["https://openalex.org/I4210111220"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jean-Marie Bruey","raw_affiliation_strings":["2Gossamer Bio, Inc., San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Gossamer Bio, Inc., San Diego, CA, United States","institution_ids":["https://openalex.org/I4210111220"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5049579219","display_name":"Roham T. Zamanian","orcid":"https://orcid.org/0000-0002-0734-0994","observed_orcids":["https://orcid.org/0000-0002-0734-0994"]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Roham T. Zamanian","raw_affiliation_strings":["6Stanford University School of Medicine, Stanford Medicine, Stanford, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Stanford University School of Medicine, Stanford Medicine, Stanford, CA, United States","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"OA1201","last_page":"OA1201"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10870","display_name":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10870","display_name":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10728","display_name":"Pulmonary Hypertension Research and Treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11189","display_name":"Transplantation: Methods and Outcomes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/idiopathic-pulmonary-fibrosis","display_name":"idiopathic pulmonary fibrosis","score":0.9980000257492065},{"id":"https://openalex.org/keywords/pulmonary-fibrosis","display_name":"pulmonary fibrosis","score":0.7459999918937683},{"id":"https://openalex.org/keywords/receptor-tyrosine-kinase-inhibitors","display_name":"receptor tyrosine kinase inhibitors","score":0.8320000171661377},{"id":"https://openalex.org/keywords/extracellular-matrix-remodeling","display_name":"extracellular matrix remodeling","score":0.847000002861023},{"id":"https://openalex.org/keywords/epithelial-mesenchymal-transition","display_name":"epithelial-mesenchymal transition","score":0.8989999890327454},{"id":"https://openalex.org/keywords/collagen-turnover","display_name":"collagen turnover","score":0.9369999766349792},{"id":"https://openalex.org/keywords/myofibroblasts","display_name":"myofibroblasts","score":0.9020000100135803},{"id":"https://openalex.org/keywords/alveolar-type-ii-cells","display_name":"alveolar type II cells","score":0.8169999718666077},{"id":"https://openalex.org/keywords/inhalation-therapy","display_name":"inhalation therapy","score":0.7070000171661377},{"id":"https://openalex.org/keywords/single-cell-transcriptomics","display_name":"single-cell transcriptomics","score":0.6919999718666077}],"concepts":[{"id":"https://openalex.org/C2778341716","wikidata":"https://www.wikidata.org/wiki/Q2290446","display_name":"Idiopathic pulmonary fibrosis","level":3,"score":0.7549999952316284},{"id":"https://openalex.org/C189165786","wikidata":"https://www.wikidata.org/wiki/Q193825","display_name":"Extracellular matrix","level":2,"score":0.7192000150680542},{"id":"https://openalex.org/C162317418","wikidata":"https://www.wikidata.org/wiki/Q252857","display_name":"Transcriptome","level":4,"score":0.605400025844574},{"id":"https://openalex.org/C2780559512","wikidata":"https://www.wikidata.org/wiki/Q605709","display_name":"Fibrosis","level":2,"score":0.5963000059127808},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.5879999995231628},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.5638999938964844},{"id":"https://openalex.org/C2779733811","wikidata":"https://www.wikidata.org/wiki/Q5531562","display_name":"Gene signature","level":4,"score":0.5224000215530396},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4767000079154968},{"id":"https://openalex.org/C2781244666","wikidata":"https://www.wikidata.org/wiki/Q32446","display_name":"Pulmonary fibrosis","level":3,"score":0.43970000743865967},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.43309998512268066},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.4018000066280365},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.39660000801086426},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.3903999924659729},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.38179999589920044},{"id":"https://openalex.org/C28406088","wikidata":"https://www.wikidata.org/wiki/Q5571762","display_name":"Extracellular","level":2,"score":0.3781999945640564},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3709999918937683},{"id":"https://openalex.org/C2777543607","wikidata":"https://www.wikidata.org/wiki/Q1153419","display_name":"Interstitial lung disease","level":3,"score":0.3709999918937683},{"id":"https://openalex.org/C2780930700","wikidata":"https://www.wikidata.org/wiki/Q1128595","display_name":"Pulmonary hypertension","level":2,"score":0.3517000079154968},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.34700000286102295},{"id":"https://openalex.org/C127716648","wikidata":"https://www.wikidata.org/wiki/Q104053","display_name":"Phenotype","level":3,"score":0.33480000495910645},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.30640000104904175},{"id":"https://openalex.org/C2780171596","wikidata":"https://www.wikidata.org/wiki/Q15149723","display_name":"Nintedanib","level":4,"score":0.2996000051498413},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.2808000147342682},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2513999938964844}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1183/13993003.congress-2025.oa1201","doi":"https://doi.org/10.1183/13993003.congress-2025.oa1201","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2025.oa1201","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular pathology and functional genomics","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9907000064849854}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4416634766","https://openalex.org/W4416635683","https://openalex.org/W4408555871","https://openalex.org/W4292794465","https://openalex.org/W4404104093","https://openalex.org/W4416634205","https://openalex.org/W4408555553","https://openalex.org/W7130518282","https://openalex.org/W4205335764","https://openalex.org/W4410030587"],"abstract_inverted_index":{"Introduction.":[0],"Seralutinib,":[1],"an":[2],"inhaled":[3,211],"receptor":[4],"tyrosine":[5],"kinase":[6],"inhibitor":[7],"under":[8],"development":[9,205],"for":[10,213],"pulmonary":[11,14,66],"hypertension,":[12],"including":[13,119,178],"arterial":[15],"hypertension":[16],"and":[17,58,81,91,123,132,144,163,183],"interstitial":[18],"lung":[19,53,215],"disease,":[20],"reduced":[21],"circulating":[22,77],"proteins":[23,78,113],"associated":[24,159],"with":[25,88,93,160],"extracellular":[26],"matrix":[27],"(ECM)":[28],"remodeling":[29],"in":[30,49,79,117,127,190],"the":[31,148,204],"phase":[32],"2":[33],"TORREY":[34,80],"trial":[35],"(":[36],"NCT04456998":[37],").":[38],"To":[39],"further":[40],"investigate":[41],"its":[42],"antifibrotic":[43],"potential,":[44],"we":[45],"identified":[46,75],"seralutinib-associated":[47],"signatures":[48,73],"a":[50,196,209],"human":[51],"precision-cut":[52],"slice":[54],"(PCLS)":[55],"fibrosis":[56,67],"model":[57],"mapped":[59,99],"them":[60],"to":[61,100],"scRNAseq":[62,103],"profiles":[63],"from":[64,76],"idiopathic":[65],"(IPF)":[68],"patient":[69],"lungs.":[70],"Methods.":[71],"Seralutinib-associated":[72],"were":[74,98,125],"RNA-seq":[82],"analysis":[83],"of":[84,206],"PCLS":[85,149],"cultures":[86],"stimulated":[87],"pro-fibrotic":[89],"cocktail":[90],"treated":[92],"10":[94],"\u03bcM":[95],"seralutinib.":[96],"Signatures":[97],"seven":[101],"public":[102],"datasets":[104],"(80":[105],"IPF;":[106],"58":[107],"controls;":[108],"486,114":[109],"cells).":[110],"Results.":[111],"ECM-related":[112],"decreased":[114],"by":[115],"seralutinib":[116,151,207],"TORREY,":[118],"COL1A1,":[120],"COL6A3,":[121],"COL24A1":[122],"ITGB1,":[124],"upregulated":[126],"IPF":[128,175,191],"myofibroblasts,":[129],"fibroblasts,":[130,179],"AT2":[131],"endothelial":[133],"cells.":[134],"Top":[135],"enriched":[136],"pathways":[137,188],"included":[138],"ECM":[139],"organization,":[140],"epithelial-mesenchymal":[141],"transition":[142],"(EMT),":[143],"collagen":[145],"turnover.":[146],"In":[147],"model,":[150],"significantly":[152,171],"reversed":[153],"fibrotic":[154,214],"patterns,":[155],"downregulating":[156],"262":[157],"genes":[158],"ECM,":[161],"EMT":[162],"epithelial":[164],"repair":[165],"pathways.":[166],"This":[167],"gene":[168],"signature":[169],"is":[170],"elevated":[172,189],"across":[173],"many":[174],"cell":[176,193],"populations":[177],"AT2,":[180],"secretory":[181],"cells":[182],"macrophages.":[184],"Conclusions.":[185],"Seralutinib":[186],"downregulated":[187],"disease-relevant":[192],"populations,":[194],"suggesting":[195],"broad,":[197],"multi-cellular":[198],"impact":[199],"on":[200],"fibrosis,":[201],"thus":[202],"supporting":[203],"as":[208],"novel":[210],"therapy":[212],"diseases.":[216]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2025-11-25T00:00:00"}